Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure-Reference-Cited by-同舟云学术

Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure

Published:2017-08 Issue:2 Volume:32 Page:221-237.e13
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Guler Gulfem Dilek,Tindell Charles Albert,Pitti Robert,Wilson Catherine,Nichols Katrina,KaiWai Cheung Tommy,Kim Hyo-Jin,Wongchenko Matthew,Yan Yibing,Haley Benjamin,Cuellar Trinna,Webster Joshua,Alag Navneet,Hegde Ganapati,Jackson Erica,Nance Tracy Leah,Giresi Paul Garrett,Chen Kuan-Bei,Liu Jinfeng,Jhunjhunwala Suchit,Settleman Jeff,Stephan Jean-Philippe,Arnott David,Classon Marie

Funder

IHC

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference74 articles.

1. The molecular hallmarks of epigenetic control;Allis;Nat. Rev. Genet.,2016

2. LINE-1 induces hTERT and ensures telomere maintenance in tumour cell lines;Aschacher;Oncogene,2016

3. HDAC-mediated suppression of histone turnover promotes epigenetic stability of heterochromatin;Aygun;Nat. Struct. Mol. Biol.,2013

4. A problem of persistence: still more questions than answers?;Balaban;Nat. Rev. Microbiol.,2013

5. High-resolution profiling of histone methylations in the human genome;Barski;Cell,2007

Cited by 182 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer drug-tolerant persister cells: from biological questions to clinical opportunities;Nature Reviews Cancer;2024-09-02

2. Targeting transposable elements in cancer: developments and opportunities;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

3. Cancer plasticity in therapy resistance: Mechanisms and novel strategies;Drug Resistance Updates;2024-09

4. Drug tolerant persister cell plasticity in cancer: a revolutionary strategy for more effective anticancer therapies;Signal Transduction and Targeted Therapy;2024-08-14

5. YY1 downregulation underlies therapeutic response to molecular targeted agents;2024-08-06